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Abstract
Background: Mild depression is a common patient complaint in primary care, potentially
impairing role function in multiple dimensions, at high emotional and economic cost to
individuals, families, and society. Barriers to care include lack of access to Mental Health
Specialists, financial constraints and stigma, all of which can cause escalation of symptoms to
the point of disability and are magnified in underserved populations.
Purpose: The primary goal of this quality improvement (QI) project was to improve depression
symptoms using the evidence-based mobile app IntelliCare to deliver Cognitive Behavioral
Treatment (CBT) as part of an eight-week treatment protocol.
Methods: Mildly depressed adult primary care patients (PHQ-9 score 5-9) meeting inclusion
criteria were asked to participate in an eight-week collaborative protocol in which they used the
IntelliCare app at least weekly. Bi-weekly questionnaires were administered assessing patient
symptoms, app usage and patient concerns. A post-intervention PHQ-9 was done at eight-weeks.
Results: The majority of participants (67%) completed the protocol with a 53% improvement in
post-intervention PHQ-9 scores which was statistically significant based by Wilcoxon MatchedPairs analysis (p<0.01).
Implications to Practice: Willingness of patients to use the mobile health app IntelliCare with
improvement in their depression symptoms support further study of its use in practice.
Conclusion: Evidence-based mobile apps such as IntelliCare as part of a treatment plan for mild
depression may help decrease barriers to treatment for depression and improve patient outcomes.
Keywords: depression, primary care, mobile apps, telehealth, adults
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Using Mobile Health to Improve Mild Depression Outcomes in Adult Primary Care
Introduction
The World Health Organization (WHO) ranks unipolar depression as the 11th leading
cause of disability and mortality in the world, with primary care clinicians administering
treatment 67% of the time through pharmacotherapy, counseling, or a combination of both
(Murray et al., 2010). Unipolar depression is the most prevalent mental health problem across
the globe and is responsible for “10 million disability-adjusted life years lost” annually in the
U.S. at a dollar cost in the billions yearly (Collins et al., 2011). Treatment as usual (TAU)
consisting of assessment, counseling, and pharmacotherapy if indicated, followed by a period of
“watchful waiting” and reevaluation of patient’s symptomatology at a later date. Collaborative
care including referral to a mental health specialist (MHS) as well as primary care follow-up has
been shown to improve outcomes compared to TAU but is limited by multiple barriers including
lack of access to specialists, which is magnified in underserved populations; expense, stigma,
and unwillingness on the part of the patient to be referred.
According to the DSM-5 (2013), Unipolar Depression, or Major Depressive Disorder
(MDD), is a common and serious medical illness that negatively affects an individual, with
symptoms ranging from mild to severe, with increased risk for suicidality. In 2016 suicide was
the 10th leading cause of death in the U.S., and the fourth leading cause in adults between the
ages of 35 and 54 according to the National Institute of Mental Health (NIMH, 2016).
Inadequately treated mild depression can escalate to severe MDD, with risk for suicidality,
significant comorbidity, psycho-social and physical impairment, and role dysfunction and
disability, at high personal and financial cost to the individual and society. Estimated treatment
costs of depression in the U.S. are estimated to be as much as 60 billion per year, and do not

USING MOBILE HEALTH TO IMPROVE MILD DEPRESSION

7

include costs related to days absent from work or the intangible negative effects on role function,
educational achievement, and family structure (Insel, 2011).
Barriers to adequate treatment of mild depression include lack of access to clinicians, fear
of being stigmatized, geographical, time and financial constraints (Kessler, 2012). All of these
are magnified in minority and underserved populations, increasing the risk for greater health care
disparities with negative outcomes, and emphasize the need to implement effective, evidencebased, accessible treatment plans utilizing all available resources, including mobile-health
technology.
Background
In the U.S., major depression ranks second among all diseases and injuries as a cause of
disability, with a high percentage of depressed outpatients being treated by primary care
clinicians as compared to psychiatrists (Gaynes, 2017). Unipolar depression is described as a
continuum of symptoms ranging from subclinical, mild, and moderate to severe major
depression. According to the DSM-5 (2013), criteria for MDD include depressed mood or loss
of interest or pleasure in daily activities for two weeks or more; impaired social, occupational or
educational functioning; and specific symptoms of depressed mood including significant weight
change or change in appetite, insomnia or hypersomnia, psychomotor agitation or retardation,
fatigue or loss of energy; inappropriate guilt or worthlessness, and diminished ability to
concentrate or indecisiveness, and suicidality. Mild depression is defined as two to four of these
symptoms, experienced for a two-week period, along with distress or psychological impairment
(Lyness, 2018).
Lifetime prevalence of unipolar depression is estimated to be 12% in the general
population, and up to 20% in the chronically ill (Gaynes, 2017). The WHO ranks MDD as the
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fourth leading cause of disability worldwide with higher prevalence in economically advantaged
nations and predicts that by 2020 it may be the second (Kessler, 2012). In primary care, where
there is a high rate of chronic comorbid medical conditions, effective care for depression is
critical, and often limited by patient perceived treatment stigma, discontinuation of prescribed
anti-depressant medications, deficits in provider skills related to treatment, financial and time
constraints on the part of patients, transportation issues, and limited access to mental health
specialists (Kessler, 2012). These problems may be magnified in underserved elderly, minority,
or low-income populations (Marshal et al., 2011).
Presentation of Mild Depression
The majority of patients experiencing symptoms of mild depression first present to their
PCP, with treatment as usual (TAU) consisting of interview and evaluation to rule out underlying
pathology, followed by “watchful waiting” for several weeks to ensure that symptomatology is
not worsening, and/or pharmacotherapy. An effective adjunct to TAU is Cognitive Behavioral
Therapy (CBT), which is the most researched form of treatment for adult depression and has
been shown to be more effective than pharmacology alone (Cuijpers et al., 2013). The goal of
CBT is to reduce the negative emotional impact of unpleasant thoughts with more realistic and
adaptive ones by first identifying them, reappraising them, then challenging the negativity and
replacing it with more accurate and adaptive reasoning. The initial thoughts are then reevaluated and the intensity of the emotions regarding them is rated. This process is repeated for
different situations leading to more rational and adaptive thinking, and less negative reality and
self-perception, which helps to break the cycle of depression (Beck, 1997).
Collaborative Care Treatment Model
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Collaborative care is a treatment model which integrates TAU with CBT administered by
a mental health specialist (MHS) and has been demonstrated to be effective in depression
treatment (Gaynes, 2017). It can be used in primary care as part of a structured treatment plan
that may involve pharmacotherapy, scheduled office visits, and measurement-based care
(Gaynes, 2017). Meta-analyses of practice models utilizing collaborative care have been shown
to be superior to pharmacotherapy alone, and lower risk of maladaptive behaviors including drug
and alcohol abuse, suicidal ideation, and days missed from work (Lyness, 2018). Treatment
goals are decreased depressive symptoms, improved general functioning, and prevention of
severe MDD. As previously discussed, due to barriers to care, access to traditional collaborative
care is often limited. The burden of inadequately treated mild depression in primary care not
only results in economic hardship for individuals, families, society, and the healthcare system,
but intangible costs which put patients and their families at greater risk for negative outcomes in
terms of life goals, family structure, educational achievement, susceptibility to drug abuse, etc.,
and emphasizes the need for innovative, alternative, evidence-based treatments.
Mobile Health
Advances in technology and the widespread adaptation of “smart-phone” usage in all
socio-economic and isolated areas of our society have created a new, potential means for
engaging patients with mild depression in collaborative treatment through evidence-based
therapy platforms. According to PEW research, as of 2015 64% of all U.S. adults own a smartphone and use it regularly (Smith, 2015). Rates of smartphone ownership and use are high
within low-income populations, which can enable the traditionally underserved to access mental
health support via mobile app (Lui, J., & Marcus, D., 2017). One in five smart-phone owners
report having a health-related app downloaded to their phone, of which at least seven percent
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target mental health (Rainie & Perrin, 2017). Data supporting usage of mobile apps in
depression treatment includes a 2015 meta-analysis of effectiveness of psychological treatments
for depression in primary care, by Linde, et al., in which remote guided self-help utilizing CBT
was shown to yield outcomes similar to face-to-face encounters with mental health providers. In
2016 the American Medical Association (AMA) published a newsletter in support of the use of
mobile apps that “have a clinical evidence base to support their use” (AMA, 2016). A recently
published study reviewing utilization of mobile apps in behavioral health recommended them as
evidence-based approaches to depression treatment to improve access and outcomes, and defined
core principles that can be used to guide care including team-based, evidence-based,
measurement-based, and population-based (Raney, Bergman, Torous & Hasselberg, 2017).
The principle of using measurement to define depression level as compared to symptom
description is recommended by the U.S. Preventive Services Task Force, who released a
statement in 2016 supporting depression screening measurement for all adults, using a validated
instrument such as the PHQ-9 (USPSTF, 2016). The PHQ-9 (Appendix A) can be used to
measure symptoms of depression in primary care patients and provide a baseline for comparison
of pre-post intervention quality outcomes. The instrument can be used without permission.
Annual depression screening in the 12 and older population is one of the quality metrics
recommended by the USPTFS (2015) for primary care providers (PCP’s), thereby created an
impetus to incorporate such measures in primary care and will be utilized in this QI project.
Purpose Statement
Risk of role dysfunction and disability in inadequately treated mildly depressed adult
primary care patients, as indicated by worsening PHQ-9 scores due to decreased access to
treatment, can be effectively addressed by patient usage of an evidence-based mobile mental
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health app as an adjunct to care. The purpose of this DNP project is to implement a guided
treatment protocol for mild depression in primary care utilizing IntelliCare, an evidence-based
mobile app, as an adjunct to treatment, with the goal of increasing access to care and improving
outcomes.
Organizational “Gap” Analysis of Project Site
The project site was an adult primary care practice on the East Coast where
approximately five to ten percent of patients seen daily present with symptomatology of
depression. There was no protocol in place for management of depression, and measures such as
the PHQ-9 were not routinely used. There was no universal standard for follow-up, and
outcomes regarding effectiveness of treatment were not measured. Due to the serious health
consequences of inadequately treated mild depression and its prevalence in this patient
population, this quality improvement (QI) project consisted of an eight-week guided protocol
utilizing the mental health app IntelliCare as an adjunct to treatment of mildly depressed patients
that m inclusion criteria and were willing to participate.
Literature Review
To study the current standard of care for mild depression in primary care, gaps in care,
and innovations in treatment utilizing mobile applications (apps) a comprehensive search of the
literature was conducted using the following databases: Cochrane, CINAHL, PubMed, AHRQ,
PsycInfo, Medline and Up to Date. (MeSh) terms “depression, adults, primary care, telehealth
and mobile health” were entered in various combinations. Inclusion criteria consisted of full-text
articles available in English and focused on the adult population between 2008 and present;
exclusion criteria included articles focusing on age groups other than adult; articles not available
in English, and articles focusing on severe major depression or severe mental illness and
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specialty care. A total of 201 articles were identified using the above search criteria, of which
28 were found to be relevant to the study. Of these, six are systematic reviews/meta-analysis,
four are RCT’s, two are pilot studies, and the rest are descriptive. Levels of evidence
incorporated in this review include three meta-analyses at Level 1A, several RCT’s at Level 1B,
and a review and several semi-experimental cohort studies at level 3B, based on Johns Hopkins
strength of evidence guidelines (Newhouse, Poe, Pugh & White, 2005).
Collaborative Care versus Treatment as Usual (TAU) with Pharmacology Alone
According to a meta-analysis by Linde et al. (2015), MDD is expected to be first on the
list of disorders for highest burden of disease in high-income countries by 2030. Most patients
with mild symptoms of MDD are initially seen in primary care, where barriers to access and
limited resources potentially create a gap in care. The meta-analysis reviewed currently
available studies comparing collaborative care versus TAU or placebo. Thirty studies with n =
5,159 patients met inclusion criteria. Categories of comparison to placebo included in-person
CBT, in-person problem-solving, in-person interpersonal psychotherapy, remote therapist CBT,
remote therapist problem-solving, and guided self-help CBT. Results of this meta-analysis
“suggest that the differences between different types of psychological treatments are minor”, and
remote, therapist-led and guided-self-help can be similarly effective as in-person therapy (Linde
et al., 2015). Level of evidence meets 1A criteria. In a meta-analysis by Archer et al. (2012) of
79 randomized trials with more than 24,000 patients, collaborative care involving a treatment
plan was much more effective in reducing baseline symptoms of depression by greater than or
equal to 50%, than pharmacotherapy alone. These benefits persisted up to 24 months (Archer et
al., 2012). Level of evidence meets 1A criteria. In a meta-analysis of 37 randomized trials
involving more than 12,000 patients, support for collaborative care including a structured
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treatment plan including pharmacotherapy with follow-up by office visit, telephone or email
contact, was found to have a significant but clinically small positive effect compared to just
pharmacotherapy, which persisted up to five years in a meta-analysis (Gilbody et al., 2006).
Level of evidence meets 1A criteria, supporting the role of collaborative care in promoting
positive outcomes in depression treatment. In a smaller meta-analysis of 2000 patients,
remission occurred in more patients who received collaborative care than those who received just
medication management (Sighinolfi et al., 2014). Level of evidence is 3B due to the smaller
sample size. A Cochrane review of self-help-based CBT through a variety of media including mhealth is currently being conducted by Rummel-Kluge, Dietrich, and Koburger (2015), focusing
on primary outcomes of treatment efficacy, as well as improvement in quality of life and overall
symptoms, adherence to CBT/behavioral based self-help, adverse effects, and economic benefits.
Results of this analysis are expected to align with the above findings.
In a recent RCT study published in JAMA (Rollman et al., 2017) three groups of primary
care patients diagnosed with mood or anxiety disorder (n = 704) were randomized to three study
arms: one treatment as usual by PCP, one treatment utilizing an online eight-session
Computerized Cognitive Behavioral Therapy (CCBT) protocol, and one CCBT plus an internetbased support group. Results indicated that patients using CCBT reported greater improvements
in mood at the six-month mark. Level of evidence meets 1A criteria, in support of collaborative
care administered via a non-traditional approach.
Telehealth Based Collaborative Care versus TAU
Studies specifically addressing the role of tele or mobile health in the treatment of
depression include a 2014 descriptive study by Sheldon et al., Sheldon’s group discussed gaps in
the care of depressed primary care patients emphasizing that while most people in the U.S. are
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treated by primary care providers for depression, often treatment is just antidepressant
medication with low adherence rates. According to their review, less than 10% of primary care
patients with depression receive evidenced-based psychotherapy, with limited access especially
pronounced in low-income communities where issues such as transportation, child-care, fees for
care may play a larger role as barriers to care. They developed a telephonic based behavioral
activation treatment (TASC) to reduce depression, based on teaching individuals to monitor their
mood and daily activities, and increase activities which have the potential for providing positive
experiences. The TASC program was implemented in eight primary care clinics in an urban
public health setting. Up to five phone calls were made to participants over time, with general
improvements on PHQ-9 scores. Due to the lack of statistical analysis, this study is graded as
4B, but underscores the ability of phone-based interventions to help improve access to care
(Sheldon, 2014). In a 2016 RCT specifically focusing on benefits of telehealth in depression
treatment conducted by Salisbury, et al., in England, 609 patients recruited from 43 general
practices with PHQ-9 scores of 10 or more were assigned to two treatment groups, 307 in
intervention group and 302 in the TAU group. TAU consisted of initial face to face visit, with or
without pharmacology. The treatment plus group had an initial visit, and possibly pharmacology
prescribed, but also utilized a web portal with links to several web-based self-help programs,
with “advisees” placing phone calls to participants over a four-month period. The primary
outcome of the study was defined as a reduction in PHQ-9 score by at least five points by the
fourth month. Results demonstrated that 27% of participants in the treatment plus group reduced
their PHQ-9 scores by at least five points, compared to 19% in the treatment as usual group.
Effects were sustained at the eight and 12-month mark, with gradual diminishment of between
group differences. Another RCT comparing TAU to an online depression care management
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system through patient EMR, was conducted in Washington State in 2010 (Katon, et al., 2010).
A total of 208 patients, all of whom who had been seen in primary care and started antidepressant
medication, were randomized to the TAU group or to the intervention group, where three online
contacts with a trained psychiatric nurse were conducted over five months. For patients in the
TAU group no additional interventions were provided, but no treatment was withheld, including
follow up visits, mental health specialist referral, medication changes, and patient initiated online
messaging, etc. In the treatment group, patients received a welcome email by the nurse with
links to an online depression assessment and to questions regarding medication. Patient
satisfaction surveys were conducted at the five-month mark. The primary outcome measure was
depression score as measured by Symptom Checklist Scale (SCL). Approximately 55% of
patients in the treatment group compared to 41% of patients in the TAU group experienced 50%
or more improvement of SCL scores, again supporting usage of a tele-health-based treatment
algorithm. Both RCT trials are graded at the 1B level of evidence and provide support for the
use of tele-health and mobile health as an adjunct to treatment as usual.
In terms of the global stage, one current trial in Denmark is the RADMIS-reducing the
rate and readmissions among patients with unipolar and bipolar disorder using smartphone-based
monitoring and treatment study (Faurholt-Jensen, et al., 2017). Rural communities in India have
been identified as being particularly underserved and the use of mobile apps is being addressed
in the SMART trial-the Systematic Medical Appraisal Referral and Treatment Mental Health
Program using mobile-based mixed intervention methods (Maulik, Devarapalli, Kallakuri,
Praveen Jha, & Patel, 2015) Recognizing the need for accessible strategies at the onset of
depressive symptoms, Romania is currently conducting an RCT trial using smartphones for
large-scale dissemination of CBT, with a control group of patients whose PHQ-9 scores
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demonstrate no depression and a treatment group of those scoring in the mild depression range.
The primary end points are to reduce vulnerability to depression and improve symptoms (Giosan,
Mogoase, Cobeanu, Szentagotai Tator, Muresan, & Boian, 2016).
Evidence-based Mental Health Apps
As of 2015, 165,000 health-related apps have been released for Android and Apple
platforms, with an estimated seven percent targeting mental health (Van Ameringen, Turna,
Khalesi, Pullia & Patterson, 2017). Due to the extensive number of apps, this literature review
focused on “evidence-based” apps which were studied in cohort or RCT trials, available free of
charge, and in English.
In a 2013 systemic review by Donker et al., eight papers describing five apps for
depression treatment showed significant reduction in symptoms related to app usage, supporting
an apps potential to be effective and improve access to treatment. Ease of use, helpfulness and
satisfaction ratings by app users indicated acceptability. Technical issues related to connectivity,
and problems with downloading the apps occurred but were not insurmountable. The review
supported the use of mobile health (mHealth) utilizing CBT as an option for treatment of mild to
moderate depression, either as a stand-alone treatment or in conjunction with a guided treatment
protocol such as the one being implemented in this QI project (Donker et al., 2013). The authors
of this review emphasize the fact that although many apps are getting to market, there are very
few apps that meet the criteria for evidence-based, and this is an area in which the public needs
to be educated (Donker et al., 2013). In a meta-analysis conducted by Firth (2017), 18 RCTs of
app interventions for depression versus no apps found that there was a significant reduction in
depression among app users, further strengthening support for using evidence-based apps as an
adjunct for depression treatment, at an evidence level of 1A. Firth’s analysis was reviewed by
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Muoio in “Mobile Health News” in support of mHealth utilization to treat depression, with the
caveat that future studies need to be conducted (Muoio, 2017).
Two promising evidence-based app include a mobile phone app based on “Behavioral
Activation Treatment for Depression” (BATD), called “Moodivate”, which is currently being
studied in an ongoing clinical trial of depression in primary care (Dahne et al., 2017). As of the
time of writing of this review, results are not yet available. Prime-D, a mobile app utilizing
“social networking, goal setting, and a mental-health coach” to deliver weekly texts (Arean, et
al., 2017) demonstrated similar improvements in PHQ-9 scores at the end of the trial but had
only 36 participants and was not randomized, consistent with 3B level of evidence.
SuperBetter, a smartphone and web-based app for the treatment of depression, recently
underwent an RCT study in collaboration with researchers at the University of Pennsylvania. In
the RCT study of n=283, participants were recruited through public announcements on the “Penn
Authentic Happiness Web Site”, where they were directed to an internet site to take a depression
screening tool. Participants meeting score criteria were randomly assigned to one of three
groups: a version of the app using CBT with “Positive Psychotherapy” (CBT/PPT); a version
using just the SuperBetter app (SB), and a waiting list. Preliminary results showed that SB
participants achieved greater reductions in depression scores than those in the FG arm, but there
was no significant difference in symptom improvement for CBT/PPT versus SB (Roepke et al.,
2015). Level of evidence for this RCT is 1A.
IntelliCare is a mobile app suite developed by researchers from Northwestern University
led by psychologist David Mohr, consisting of 13 self-help-based CBT apps which utilize
positive-psychology and physical-activity based interventions and can be down-loaded on
android and apple supported smartphone, tablet or computer (Mohr, et al., 2017), (see Appendix
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B). The apps are free to the public and available on both android and apple platforms, though
limited to three apps on Apple devices. The app was piloted by the Northwestern research group
in a 2016 one-arm study of patient outcomes in mild depression, where patients were recruited
over an eight-week period and were taught to use the IntelliCare app with weekly text check-in
with coaches. At the end of the trial 37% of 99 participants had no symptoms of depression,
40% showed PHQ-9 score improvement, and 22% met criteria for referral, i.e., a PHQ-9 score
greater than or equal to 10 (Mohr, et al., 2017). Due to lack of randomization and a control
group, evidence level is 3B, providing evidence for efficacy based on a semi-experimental
design. Subsequent to this pilot, the NIH has sponsored three additional clinical trials using
IntelliCare.
Summary of Literature Review
In summary, the literature review supports the fact that limited access to psychiatric and
behavioral therapist-based care for depression is a serious treatment barrier and renders most of
mild depression treatment to primary care. Collaborative protocols are lacking, and care as usual
often consists of pharmacotherapy and sporadic provider visits, which the literature shows is
inferior in producing positive outcomes as compared to a comprehensive, guided treatment plan.
Using tools such as the PHQ-9 to document level of depression is not yet the standard of care but
is supported by the literature as a validated measure to document outcomes (USPTFS, 2015).
The review also supports the use of evidence based mobile apps in the treatment of
depression in primary care, with the goal of improving patient access and outcomes. Limitations
of the review include the fact that in the RCT’s supporting use of tele-health, web-based, or
mobile app interventions, it is not possible to determine how much of the positive effect seen is
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due to the intervention or to other factors not controlled for, such as treatments rendered that are
not recorded, life style changes, medication changes, and possibly respondent bias.
The “immaturity” of evidence in this rapidly developing field (Peiris, Miranda, & Mohr,
2017) is being addressed in several ways including ongoing RCT trials and by using wellestablished collaborative care app protocols when possible, that involve close follow-up in the
clinical setting.
Evidence Based Practice: Verification of Chosen Option
After review of the literature finding support of the utilization of an evidence-based CBT
mobile app as an adjunct to treatment of mild depression, a guided treatment protocol utilizing
IntelliCare was developed by this DNP student and is the focus of this paper. The IntelliCare App
Suite developed by researchers from Northwestern University led by David Mohr (2017), is free,
available in English, and can be accessed on both Android and Apple operating systems.
IntelliCare is currently being studied in two NIH trials and preliminary data from an eight-week
study completed in October of 2018 has been favorable in terms of participant completion (NIH,
2018). The fact that this suite is being studied by the NIH factored in the decision to utilize this
app in this QI project, where the goal was to offer patients access to effective evidence-based
treatment which they can use during their enrollment and thereafter, to improve their depression
symptoms and outcomes. Although funding by the NIH does not increase evidence for a study, it
is the result of a process where the application earns points through several categories including
the investigator, innovation, approach, environment, and timeline (NIH, 2018). Usability data
regarding the IntelliCare suite was very positive, with acceptable app completion times in 22
patients supporting the feasibility of app usage (Stiles-Shields et al., 2017). As of 2016, Lattie, et
al., (2016) determined that the rate of use of the IntelliCare suite of apps was higher than other
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comparable mHealth apps, which the author’s point out is a necessary requirement before
“effectiveness” can be analyzed. Ease of usability of the app supported it as the choice for this
QI project, as well as the fact that it was available on two smart-phone platforms, increasing
patient access.
Theoretical Framework/Evidence Based Practice Model
The theoretical framework behind this quality improvement project is based on the
Health Promotion Model by Nola Pender (Petiprin, 2016), where health is defined as a positive
dynamic state rather than simply the absence of disease. As exemplified in this project, health
promotion is directed at increasing a patient's level of well-being, which in this project is
improvement in symptoms of mild depression.
Pender’s model describes the multidimensional nature of people as they interact within
their environment to pursue health, and focuses on individual characteristics and experiences,
behavior-specific cognitions and affects, and behavioral outcomes (Heydari & Khorashadizadeh,
2014). Health promoting behavior is the desired behavioral outcome, which makes it the endpoint in the Health Promotion Model (Appendix B). The model emphasizes 13 theoretical
components, several of which specifically apply to the design of this QI project, including
patients being more likely to engage in health-promoting behavior when it is expected to occur,
and they are assisted and supported to engage in it (Petiprin, 2016).
In this project patients agreed to perform health-promoting behaviors by participating in a
protocol where they utilized a self-help app at least once weekly and communicated with this
DNP student ideally every other week and as needed. By enlisting in this project, they
acknowledged their desire to improve their depression symptoms. Consistent with Pender’s
theory in which health promoting behavior is most likely to occur when it is expected, clear
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guidelines regarding patient expectations in the protocol were outlined for them, and they
consented to participate. Patients agreeing to be part of this project were engaging in healthpromoting behaviors to improve their depression, which according to Pender, is the desired
behavioral outcome.
Methods
This was a Quality Improvement (QI) Practice Intervention Project based on
implementation of a collaborative treatment protocol for mildly depressed primary care adult
patients utilizing the IntelliCare mobile app as an adjunct to TAU. This QI protocol involved an
eight-week treatment plan that combined initial physical and mental health office assessment,
self-help app usage, bi-weekly provider-patient communication to document patient self-report
of symptom improvement or worsening, app utilization, and patient assessment of ease of use of
the app. Quantitative measures included pre and post intervention PHQ-9 scores and when
available, bi-weekly measures of symptom status, app use, and ease of app use determined by
questionnaire. Qualitative data included patient’s comments regarding the app and are addressed
in the discussion section.
Project Site and Population
The project site was a four-provider primary care practice where this APRN DNP student
is employed in a suburban Northeastern location. The office is in a modern building on a busline, with free parking, elevator access, and private exam rooms as offices, supporting patient
confidentiality.
The project sample was drawn from a community of 63,200 people with a median age of
41.8. The ratio of males to females was .9 to 1. English was the primary language for 77% of
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the population while 7% were Spanish-speaking. Approximately 81% of the population was
Caucasian, 9% African-American, and 7% Asian. Zip codes of participants were not recorded.
Study Design
The study design was a one-group pretest post-test design using a convenience sampling
method with a recruitment goal of 25 patients. Patients who presented to this DNP students
primary care practice between August and December of 2018 with symptoms of depression, or
were at risk for depression, were asked to complete the PHQ-9 depression screening tool. They
underwent appropriate physical examination including detailed review of systems and history, as
well as diagnostic testing when indicated. Inclusion criteria consisted of being age 18-64, having
access to an Android or Apple smart-phone and the ability to use it; not having any serious
mental health comorbidity or history of suicidality, and being able to communicate in English.
Patients on anti-depressant medications were not excluded from the protocol if they met other
inclusion criteria. Patients who scored in the mild depression range (PHQ-9 scores of five
through nine) and who satisfied other inclusion criteria were asked to participate in the eightweek QI project where they agreed to access one app from the IntelliCare Suite weekly and
engage in bi-weekly EMR or phone contact with this DNP student. They were scheduled for an
eight-week follow-up appointment where a post-intervention PHQ-9 was administered. If they
did not return for the appointment the PHQ-9 was mailed to them with a stamped return
envelope. Demographic data including age and gender was recorded. Throughout the course of
the protocol participants were reassured that if they needed an office visit or other contact during
this period they were encouraged to do so, and that it was crucial that they report any worsening
of symptoms. Patients were given a document summarizing the protocol that they could refer to.
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In the week prior to implementation of the QI project office staff was in-serviced, and
any questions addressed. The three physician practice owners each received copies of the
protocol had the app demonstrated to them. During the project implementation they were
updated regularly on the project status.
Measurement Instruments
The PHQ-9 questionnaire (Appendix A) was utilized for measurement of pre and post
intervention depression scores. It has multiple references supporting its usage as a valid, reliable
measure of depression (USPSTF, 2016), and does not require permission to be used. The
diagnostic validity and reliability were established in several primary care and obstetrical studies
and was shown to have both sensitivity and specificity scores of 88% for Major Depressive
Disorder (USPSTF, 2016).
Another measurement tool in this study consisted of a bi-weekly questionnaire developed
by this DNP student (Appendix C) in which patients were asked to rate their depression
symptoms as the same, improving, or worsening; whether they had accessed the app; and their
rate of ease using the app. The purpose of the questionnaire was to ensure that depression
symptoms were not significantly worsening during the protocol, which would initiate referral to
an MHS and protocol cessation. A second purpose was to track issues in app usability which
might interfere with app access.

Goals, Objectives and Outcomes
Goals

Objectives

Outcomes

The primary goal of this DNP

A protocol was developed

PHQ-9 scores for the 17

project was to improve

which addresses the gap in

patients completing the
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depression outcomes

practice between large

protocol were improved by an

measured by PHQ-9 scores in

numbers of adults who screen

average of 53% by the end of

adult primary care patients

positively for mild depression

the eight-weeks. This was a

through a guided treatment

based on PHQ-9 scores, but

significant decrease in

protocol utilizing an evidence- do not have a specific

depression scores as

based mobile app as an

treatment plan in place to

determined by Wilcoxon

adjunct to care.

improve outcomes.

matched-pairs test of pre and

The treatment protocol was
implemented utilizing bi-

post intervention scores
(p<0.01).

weekly communication with
patients with at least weekly
patient usage of the evidencebased mobile app IntelliCare.

Secondary goals of this

Patients accessed an

Despite at least three attempts

project: For patients to access

IntelliCare app at least once

to reach patients by phone or

the IntelliCare app on a

weekly determined by self-

portal at week 2, 4 and 6 to

regular basis during the

report on bi-weekly

administer bi-weekly

protocol.

questionnaires. Problems

questionnaire, contact was not

accessing the apps were

made for greater than 50% of

addressed by this DNP student respondents for at least one
as they arose and resolved

response period, leaving data

when possible.

“holes” for those weeks as
depicted by “999” in the data
fields for responses. When
meeting with patients at week
eight at least 60% stated that
they had used the app on at
least a weekly basis. 2/17
(12%) of completers stated
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they had some issue with the
app which was addressed and
resolved.

The majority of participants

At least 51% of participants

68% of protocol participants

would complete the protocol.

would complete the post-

completed the pre and post

intervention PHQ-9.

intervention PHQ-9.

Project Framework and Implementation
This QI project was implemented in August of 2018. The PDCA model was the
framework for the project (Deming, 1997) and is outlined below.
Plan: An identified gap in practice for treatment and follow-up of mildly depressed
patients in this DNP student’s practice was identified and became the focus of this QI practice
intervention project. Literature review was undertaken with development of a guided treatment
protocol utilizing the evidence-based mobile app IntelliCare, as an adjunct to treatment as usual.
Do: Appropriate patients were asked to complete the PHQ-9 to help determine their level
of depression. Patients who scored between five through nine on the PHQ-9 and met inclusion
criteria were asked if they were interested in participating in this project. Patients were provided
with a summary of the study protocol which included the bi-weekly questionnaire they were
asked to respond to. The need for timely reporting of worsening depression symptomatology was
discussed with patients and detailed in the paperwork they received.
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Descriptive, demographic data including age and gender was collected, along with patient
bi-weekly questionnaire results regarding status of depression symptoms, if apps were accessed
weekly, and patient evaluation of app ease of use. Tracking of bi-weekly questionnaire
responses was on paper, recorded on the back of their initial PHQ-9 questionnaire.
At the time of participant sign on to the project an eight-week follow-up appointment was
scheduled, and dates for bi-weekly phone or EMR patient-portal follow-up were established by
calendar and were written on the top of each participant’s questionnaire. Notes regarding these
conversations were recorded on the PHQ-9 questionnaire to allow tracking of bi-weekly patient
contact. Questionnaires were organized with newest participant on the bottom, and oldest
participants on the top, then removed at completion and placed in a folder in the locked desk
draw. Establishment of an ongoing therapeutic relationship with the patient was an important
means to assess their level of symptomatology and is a goal of the provider-patient relationship.
Patients were reassured that at any time they could stop participation in the project and were
encouraged to initiate contact if they needed to be seen in the office or were experiencing any
difficulties. They were encouraged to communicate via EMR as desired, but instructed that if a
quick response was needed, they should place a telephone call to the office, which would be
answered the day they were received barring absence of this provider; EMR response would be
within 24 hours of patient-initiated contact.
In cases where patients were on medication prior to the protocol, they were asked
whether they were taking their medication. If it was determined that patients needed an
adjustment in medication they were withdrawn from the official protocol, which happened in one
case.
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Check: Primary outcome data was statistical analysis of pre and post PHQ-9 scores after
eight weeks of treatment to determine whether the protocol completers experienced a significant
improvement in depression symptoms. Secondary outcome data included the number of patients
who “dropped-out” or did not complete the protocol with the goal of having the majority
complete. Another secondary outcome was the goal of having the majority of protocol
participants completing bi-weekly questionnaires.
Act: Based on data analysis of the primary outcome demonstrating a significant
improvement in depression symptoms, the incorporation of this guided treatment protocol into
TAU was validated. The secondary outcome of having the majority of participants complete the
protocol was achieved at 68%. The secondary outcome goal of bi-weekly communication and
questionnaire completion for most participants was not met and will need modification in future
QI projects.
Cost-Benefit Analysis/Budget
Due to this project occurring during working hours there was no additional financial cost
to accessing the office or utilizing staff while seeing patients. Time spent on phone and EMR
communication was estimated at one hour daily. For cost of packet construction, ink and paper
costs, and incidentals, see Appendix D.
In terms of benefits to practice owners in undertaking this project, there were gains
toward satisfying CMS metrics requiring depression screening by PHQ-9 as well as EMR
communication via patient portal. There was also increased patient flow due to the eight-week
scheduled follow up visit as well as any other needed visit. Cost of app usage did not increase
cost to patients above their usual technology fees, providing an equitable platform for patients to
engage in a guided treatment protocol without additional expense.
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Ethical Considerations/Protection of Human Subjects
This project was declared not to be Human Subjects Research by the appropriate
Institutional Review Board (Appendix G). In accordance with HIPAA regulations, all patient
data was confidential and data analysis was done anonymously by assigning case numbers to
patients; data was kept in a locked desk drawer. EMR access was password protected at two
levels and was HIPAA compliant.
Since the app was accessed through the patient’s cell phone or mobile device of their
choice, patients were asked to acknowledge that despite security measures any electronic or
mobile device could be breached. For those who needed instruction on downloading and
accessing the app written directions were provided in the protocol description and when
necessary they were instructed on downloading and usage during the initial office meeting. A
disclaimer stating that this DNP student has no vested interest or anything to gain from utilizing
this app was included in the packet.
Results
A total of 25 patients meeting criteria were recruited into the protocol beginning August
1 through December 31 of 2018. Demographic data on gender and age of protocol participants
are shown in Table 1. Eighty percent (n=20) of participants were females, 20% (n=5) were
males. Ages represented were from 21 to 64 with only one patient in the 61-64 category.
Table 2 depicts average pre and post PHQ-9 scores by gender. Average pre-protocol
PHQ-9 for female completers was 7.5, for males it was 7. Average post-protocol PHQ-9 for
females was 3.76 and 2 for males, representing an approximately 51% improvement for females
and a 69% improvement for males. The small sample size prohibits any meaningful analysis of
the discrepancy in score improvement by gender but may be of future interest.
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Table 3 depicts average pre and post PHQ-9 scores by age. Of note, all age groups were
represented in the initial 25 participant enrollment. The single patient in the 61-64 age group had
the highest pre-protocol PHQ-9 score and achieved the highest percentage of post protocol
improvement at 78%. Again, the sample size limits any meaningful statistical analysis to
determine significant effects due to age group but may be of future interest.
Sixty-eight percent (n=17) of protocol participants completed the pre and post PHQ-9.
Of these, the mean pre-protocol PHQ-9 was 7.2 (SD=1.78) and mean post-protocol PHQ-9 was
3.4 (SD=1.69), a 3.82 point or 53% average score improvement for completers, n=17 (see Table
4).
IBM SPSS® 25 was used to run the non-parametric Wilcoxon matched-pairs test to
determine whether there was a significant improvement in post-PHQ-9 scores after completing
the protocol. Results indicated a significant improvement in post-protocol PHQ-9 scores and are
shown in table 4 with a mean improvement of 3.82 points for completers which was statistically
significant at p<0.01. (See Table 5).
If a patient did not complete the post protocol PHQ-9, their demographics, initial PHQ-9
scores, and bi-weekly responses were excluded from analysis. One (1) patient formally
withdrew, one (1) patient experienced a catastrophic event affecting a family member, contacted
this provider, was prescribed medication, referred for therapy and was not included as a
completer. One (1) patient did return the post-intervention questionnaire by mail but was
excluded from the analysis because there was no other contact for the entire protocol. The
remaining five (5) non-completers did not return for follow-up or complete the mailed postintervention PHQ-9, excluding them from analysis.
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The secondary goal of having the majority of patients completing the protocol was
achieved with a completion rate of 68%. In terms of the secondary goal of bi-weekly contact and
questionnaire completion, for week two only 33% of patients completed the response
questionnaire, for week four 36% completed, and for week six 32% completed, despite three
attempts. These results will be addressed under discussion.
Discussion
MDD is currently the fourth leading cause of disability worldwide, and by 2020 is
predicted to be the second, at great financial and emotional cost to patients and society (Kessler,
2012). Most patients first present to their primary care provider for evaluation and treatment of
depression where their care can be limited by lack of knowledge or experience of the provider,
financial constraints, fear of stigma, and insufficient access to mental health specialists, all
accentuated in underserved populations, leading to risk of severe MDD. Innovative, evidencebased treatments are needed to address this gap in care and was the focus of this QI project.
Nola Pender’s Health Promotion Model describes health as a dynamic state between
person and environment and not just the absence of disease. This QI project exemplifies
Pender’s theory based on patients agreeing to interact with the environment, which in this project
was the IntelliCare app and protocol, to help decrease their depression symptoms and improve
their well-being. This protocol enhanced treatment as usual by utilizing a validated measure of
depression to evaluate outcomes, encouraged access to and utilization of an evidence-based selfhelp mobile app which has been shown to improve depression symptomatology, and
implemented a follow-up communication strategy that is often lacking in traditional care for mild
depression.
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Patients who used the IntelliCare app and completed this protocol experienced an average
53% improvement in their depression symptoms, supporting the use of the app as an adjunct to
treatment of mild depression in an appropriate patient population. Having a majority of patients
completing this protocol supports the feasibility of using the mobile app IntelliCare as an adjunct
to TAU that patients can access at will, free of charge, with positive outcomes and is supported
by results in NIH trials to date (Mohr, et al., 2017) (NIH, 2018). On October 29, 2018 the NIH
released preliminary results on Clinical Trial NCT02176226, with results supporting continued
use of IntelliCare based on patient usage. IntelliCare staff can be contacted online through their
website https://intellicare.cbits.northwestern.edu. IntelliCare is currently being studied at other
universities for possible modification and improvement to the app (Greene, 2018).
To address the issue of difficulty having patients respond on a bi-weekly basis, future
protocols could include just one four week “check-in” as opposed to every two weeks, with EMR
contact versus telephone, decreasing the potential barrier of phone lines being busy, messages
not being given to the protocol provider, and to facilitate patient convenience, i.e., EMR contact
can take place any time from the patients perspective. A qualitative approach with an EMR
record of the patient’s responses/comments versus a questionnaire may also increase patient
engagement and satisfaction while facilitating tracking of progress of the patient. It will also aid
the QI leader in compiling qualitative data for review.
Facilitators and Barriers
Setting facilitators included this APRN DNP student having the support of practice
owners, staff to schedule appointments, relay patient concerns to this DNP student, and answer
telephone calls during routine business hours. There was a secure EMR with patient portal
access, and an appointment schedule which allowed patients with depression to be seen for a 30-
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minute visit by this DNP student APRN provider. Document copying was also available and
utilized for protocol patient handouts. One of the practice owners agreed to be the onsite
preceptor and signed a letter stating support for the implementation of the QI project to show
support for the project. The physician providers in the office were responsible for patient
coverage for this DNP student in case of work absence or after-hours emergencies; neither of
these situations occurred.
Barriers in this setting included six patients missing their eight-week follow-up
appointment and not being rescheduled due to miscommunication with staff, necessitating a
modification in the protocol which was addressed with this DNP student’s advisor as well as the
practice owners. Mailing of post-protocol questionnaires to patients who missed their eightweek follow-up appointment was done with responses from three. A second barrier was
identified at the time of the eight-week follow-up when several patients stated they had called
regarding the bi-weekly questionnaire, but the message was not relayed. Modifications to
circumvent these barriers in the future are addressed under Discussion.
Limitations
Major limitations of the QI project included small sample size, the absence of a control
group and the gaps in bi-weekly response data. Further QI projects should involve larger number
of participants, a control group if possible, notation of anti-depressant medications the patient is
taking, and a record of patients who meet inclusion criteria but refuse participation, with their
reasons for refusal, which could help determine potential modifications to the protocol.
Changing the protocol check-in points from bi-weekly to one at the four-week mark which is a
conversation via phone or ideally EMR may facilitate better communication.
Conclusion
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In summary, the goal of this QI project was to implement a guided treatment protocol for
patients to improve depression symptoms utilizing the evidence-based mobile app IntelliCare as
a self-help, CBT-based adjunct to TAU. Based on 68% completion rate with an average of 53%
symptom improvement, the use of the IntelliCare app as an adjunct to treatment is supported.
Integration of the PHQ-9 screening into practice as well as following up of patients for an eightweek time frame were part of this protocol and will be maintained in this DNP student’s primary
care practice. This data will be shared by PowerPoint presentation with practice owners with the
goal of them implementing this protocol in their work with mildly depressed patients. A poster
presentation of this project will be presented at the 2019 ENRS conference with the goal of
increasing visibility regarding the use of evidence-based mobile apps such as IntelliCare, to
stimulate further work in this area.
Primary care providers see the majority of mildly depressed patients but have few tools
for treatment and are often overwhelmed by time constraints due to complexity of EMR systems
as well as increased patient workload. Parallel to this are patients being financially constrained
when making medical appointments by high deductibles and copays, as well as fear of stigma
and lack of availability to see mental health specialists. Mobile health apps have the potential to
play an important role in the future of mental health care-not in place of but as an adjunct to
treatment. They should be evidence-based, free, and available on a variety of smartphones and
in different languages and have contact information for support to patients. Widespread
adoption is limited by the lack of experimental evidence and need to be further studied in
ongoing RCT trials as previously discussed. The potential endpoints of improved treatment and
follow-up with consequent decreased disability, emotional and financial cost to individuals,
families, and society, are critical to the success of the healthcare system.
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Quality Improvement projects implemented by DNPs utilizing innovative, evidencebased tools are essential to achieving the triple aim of “improving the health of the population,
enhancing patient experiences and outcomes, and reducing per capita cost of care (Taylor, et al.,
2014). Further study to determine best treatment protocols in depression where mobile health
can play an acceptable and beneficial role in improving access and outcomes for patients is an
area that presents a challenge to primary care DNP providers, whose focus on translating
research into practice can improve care. The goal of improving depression symptoms and patient
outcomes is to decrease related illness and disability and improve quality of life, with economic
and emotional benefit for patients, families, society, and the healthcare system.
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Appendix A
PHQ-9: Nine-symptom Checklist
Name ______________________ Date _________
Over the last 2 weeks, how often have you been bothered
by any of the following problems?

More than Nearly
Not Several
half the every
at all days
days
day

1. Little interest or pleasure in doing things

0

1

2

3

2. Feeling down, depressed, or hopeless

0

1

2

3

3. Trouble falling or staying asleep, or sleeping too much

0

1

2

3

4. Feeling tired or having little energy

0

1

2

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself—or that you are a failure or
have let yourself or your family down

0

1

2

3

7. Trouble concentrating on things, such as reading the
newspaper or watching television

0

1

2

3

8. Moving or speaking so slowly that other people could
have noticed? Or the opposite—being so fidgety or restless
that you have been moving around a lot more than usual

0

1

2

3

9. Thoughts that you would be better off dead or of hurting
yourself in some way

0

1

2

3

(For office coding: Total Score ____ = ____ + ____ + ____)

2. If you checked
off any problem on this
questionnaire so far, how
difficult have these
problems made it for you
to do your work, take care
of things at home, or get
along with other people?

Not difficult
Somewhat Difficult
Very Difficult
Extremely difficult
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Total Score and
Depression Severity
•
•
•

•

•

0-4 No
Depression
5-9 Mild
Depression
10-14
Moderate
Depression
15-19
Moderately
Severe
Depression
Over 20
Severe
Depression
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Appendix B
Description of IntelliCare Apps
IntelliCare Hub: Uses an algorithm that manages personalized messages and
notifications for each user from the other apps within the IntelliCare framework.
Aspire: Guides user to identify the values that inspire one’s life and specific actions
someone does to live these values. Aspire helps keep track of these actions throughout the day
and supports the user in living a more purpose-driven and satisfying life.
Day to Day: Delivers a daily stream of tips, tricks, and other information throughout the
day designed to boost the user’s mood. Day to day prompts the user to work on a particular
theme each day, which changes every week. And to learn more about how to effectively cultivate
gratitude, activate pleasure, increase connectedness, solve problems, and challenge one’s
thinking.
Daily Feats: Encourages the user to incorporate worthwhile and productive activities into
the day. Users add accomplishments to the Feats calendar, where they track their positive activity
streaks and ratchet up by completing more tasks. Daily Feats helps motivate users to spend their
days in more meaningful, rewarding ways with the goal of increasing overall satisfaction in life.
Worry Knot: Teaches the user to manage worry using lessons, distractions, and other
worry management tools. Worry Knot provides a guided tool to address specific problems that a
user can't stop thinking about and provides written text about ways to cope with tangled thinking.
Worry Knot also presents statistics about progress as the user practices coping with worry, gives
daily 'tips and tricks' for managing worry and provides customizable suggestions for ways to
distract oneself.
Social Force: Prompts the user to identify supportive people in their lives and provides
encouragement for the user to get back in touch with these positive people.
My Mantra: Prompts the user to create mantras (or repeatable phrases that highlight
personal strengths and values that can motivate the user to do good and feel good). My Mantra
constructs virtual photo albums to serve as encouragement and reminders of these mantras.
Thought Challenger: Guides the user through an interactive cognitive restructuring tool
to examine thoughts that might exaggerate negative experiences, lead someone to be overcritical
and bring down one’s mood. Thought Challenger teaches the user to get into the habit of
changing perspective and moving toward a more balanced outlook on life.
iCope: Allows the user to send oneself inspirational messages and reassuring statements,
written in their own words, to help the user get through tough spots or challenging situations.
Purple Chill: Provides users with a library of audio recordings to relax and unwind.
Purple Chill teaches a variety of relaxation and mindfulness practices to de-stress and worry less.
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Move Me: Helps the user select exercises to improve mood. Move Me provides access to
curated exercise videos and to written lessons about staying motivated to exercise. This app
allows the user to schedule motivational exercise time for oneself throughout the week.
Slumber Time: Prompts the user to complete sleep diaries to track sleep. Slumber Time
provides a bedtime checklist intended to clear one’s mind before going to sleep. It also provides
audio recordings to facilitate rest and relaxation and features an alarm clock function.
Boost Me: Encourages users to select and schedule positive activities (“boosts”)
whenever the user notices a drop in his or her mood. Boost Me tracks specific activities the user
tags as positively impacting mood. This app includes animated mood tracking for pre/post
positive activities, calendar integration, and suggested activities that are auto-populated based on
past mood improvement (Mohr, et al., 2017).

USING MOBILE HEALTH TO IMPROVE MILD DEPRESSION

Appendix C
Theoretical Framework

47

USING MOBILE HEALTH TO IMPROVE MILD DEPRESSION

48

Appendix D
Protocol Summary
Thank you for your interest in participating in this project! The goal is to improve your
symptoms of depression through treatment as usual along with the use of a mobile app called
“IntelliCare” which has been shown in previous studies to help with depression if used on a
regular basis. The project is for eight-weeks.
There are two parts to this project-one will be bi-weekly communication with me via the “My
Care” patient Electronic Medical Record (EMR) portal which you will be given information on
how to sign on to when you leave here today, or via telephone, based on your preference. I will
initiate communication with you within 24 hours of this office visit through the portal or by
telephone and will do so bi-weekly for eight-weeks. I will ask you a series of three questions
(see below) on a bi-weekly basis. The portal can be used to communicate any non-urgent
questions to me regarding your care. An eight-week follow-up appointment will be scheduled
when you check out today. Please call the office at 860-313-0448 for any issues that need a fast
response.
The second part of this project asks that you download the “IntelliCare” app on to your Android
or Apple phone, tablet, or computer-whichever hardware you will be using to run the app.
Android devices facilitate downloading of the entire app suite, while apple devices, as of the
writing of this guide allow three apps to be accessed “Daily Feats”, “Worry Knot”, and “Thought
Challenger”. Apps are found in the app store on your device and are free and published in
English. I ask that you use an app at least once weekly with the goal of improving depression
symptoms. If at any time you feel your depression is worsening, I ask that you contact me at the
office. Below you will find the weekly questions I will ask you to answer. Thank you for your
interest in this project.
Bi-Weekly Questionnaire
1. How would you rate your level of depression symptoms compared to the beginning of
the protocol?
1=same, 2=Improved, 3=Worsening
2. How often have you used one of the IntelliCare apps in the last two weeks?
1=not at all, 2=at least once per week
3. How would you rate the ease of use of the IntelliCare app?
1=easy, no problems, 2=slightly challenging, occasional issues, 3=very difficult to use
Is there anything you would like to address? Please notify me by telephone 860-3130448 if you feel your symptoms are worsening.
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Appendix E
Cost Analysis
There is no direct financial benefit involved in the undertaking of this translation of
evidence into practice project for this DNP student, participants, and practice employers. No one
involved in this protocol including participants were paid to undertake this project or recommend
the IntelliCare app.
Copy Paper/Ink: Estimating 50 copies of a 2-page document describing the protocol at a
maximum estimated cost of 5 cents per copy=$4.00.
Estimating 50 copies of a 3-page Informed Consent document at 15 cents per copy=$7.50
Benefits to the practice employers included this protocol satisfying CMS recommendations for
PHQ-9 usage as well as communication with patients via the My Care EMR portal. Both these
functions help satisfy CMS Quality Measurements.
Instructions to sign on to the HIPAA protected EMR portal “My Care” are printed for every
patient at the conclusion of every office visit so do not constitute any additional charge.
Time: Patient visits took place during working hours. This APRN spent approximately five
hours per week in additional uncompensated time communicating with patients which did not
result in additional cost to employers.
Dollar Cost of DNP Project
Paper/Printing

Cost Per Page

# of Pages

# of Copies

$

Introduction

.05

2

50

5.00

Consent

.05

2

50

5.00

Total

N/A

N/A

N/A

10.00
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Appendix F
Timeline

TASKS

Obtain paper approval by faculty
advisor and IRB
Recruitment of QI participants and
implementation of protocol
Data analysis and paper revision

July
2018-

September
2018-

January
2019-

August
2018

December
2018

March
2019

April
2019

X
X
X

QI results shared with stakeholders

X

Approval of final paper by faculty
advisor

X

Submission of final paper

May
2019

X
X
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Table 1
Sample Demographics
Table 1
Number of Participants by Age Group and Gender
Age Group

Males

Females

21-30

4

2

31-40

1

5

41-50

0

6

51-60

0

6

61-64

0

1

Total=25

5 (20%) 20 (80%)
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Table 2
Pre and post PHQ-9 Scores by Gender

Table 2
Mean Pre and Post-Intervention PHQ-9 by Gender
Pre-protocol PHQ-9 Score

Post-protocol PHQ-9 Score

Mean (SD)

Mean (SD)

Female (n=13) Male (n=4)

Female (n=13)

Male (n=4)

7.5 (1.64)

3.76 (1.69)

2 (.82)

7.0 (2.00)
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Table 3
Pre and Post Intervention PHQ-9 Scores by Age Group

Table 3
Mean Pre- and Post-Intervention PHQ-9 by Age Group
Pre-Intervention PHQ-9 (n=17)

Post-Intervention PHQ-9 (n=17)

Mean

SD

Mean

SD

Age 21-30

6.83

1.83

2.6

1.52

Age 31-40

7.33

1.63

3.66

1.53

Age 41-50

8.16

1.6

5

1.63

Age 51-60

7.16

1.83

2.75

1.5

Age 61-64

9.0

0.0

2.0

0.0

Total

7.7

1.15

3.2

1.03
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Table 4
Pre-and post PHQ-9 Completer Group Scores
Table 4 Pre- and post PHQ-9 Scores
IntelliCare Completer Group (n=17)
Pre-protocol PHQ-9 Score

Post-protocol PHQ-9 Score

Mean (SD)

Mean (SD)

7.2 (1.78)

3.4 (1.69)
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Table 5
Wilcoxon Matched-Pairs Sample Test

Table 5
Wilcoxon Matched-Pairs Sample Test Protocol Completers n=17
Null
hypothesis

Test

The median
Wilcoxon Matched-Pairs
of differences Sample Test
between preand postPHQ-9 scores
=0.

Sig.

Decision

p<.01

Reject the null
hypothesis

alpha= .05

